A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole
Salvatore GentileDepartment of Mental Health, ASL Salerno 1, ItalyAbstract: Aripiprazole is a relatively novel second-generation antipsychotic belonging to the chemical class of benzisoxazole derivatives and is characterized by a unique pharmacological profile which suggests that the drug acts as a...
Guardado en:
Autor principal: | Salvatore Gentile |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a4619569aed40f89c6b6e09552bd895 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Augmentation treatment in major depressive disorder: focus on aripiprazole
por: J Craig Nelson, et al.
Publicado: (2008) -
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009) -
Aripiprazole for late-life schizophrenia
por: Jeffrey Rado, et al.
Publicado: (2010) -
Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008) -
Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre R, et al.
Publicado: (2011)